Status: Recruiting
Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab
This is a non-blinded phase 2 trial in Stage II-IIIa urothelial cancer randomizing pre-operative nivolumab with or without relatlimab to assess whether bladder preservation after dual immunotherapy would be a viable treatment option for patients responding to treatment
Participants needed: 90
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: The Netherlands Cancer InstituteUpdated: Sep 3, 2025Locations: 9
Eligibility criteria
Willing and able to provide informed consent [+10]
Subjects with active autoimmune disease in the past 2 years. Patients with diabe... [+16]